4 research outputs found
Videojuegos para el desarrollo del pensamiento crítico y el diálogo
No full textThis article takes up the results of the research carried out by the author of other article entitled Video games in the classroom: a proposal associated with the development of critical thinking (2016). Some of the concerns generated in the study are related to the guidelines for developing a proposal for the use of video games in the classroom, associated with the development of critical thinking, in a group of young Venezuelans in school between the ages of 13 and 17. We tried to understand video games as a cultural product in the Venezuelan context, the habits of video game consumption by the subjects studied and their relationship with critical thinking and the development of dialogue processes. The starting point is the analysis of the four dimensions proposed by Lipman (1998) for the study of critical thinking and the sociocultural conception of learning and the theory of Vigotsky?s Zone of Proximal Development. From the methodological point of view, the interview was used as a technique for data collection and work was done with an intentional sample, made up of two 14-year-old adolescents, who interacted with video games of different genres. It was observed that dialogue and collaboration in the face of these technologies are spontaneous and necessary behaviors to favor problem solving and decision making; thus, the guidelines proposed by Lipman and Vigotsky are formulations that allow for orienting reflections on the possibilities that media literacy can offer for the development of critical views on the media
DOR NEUROPÁTICA E CORRELAÇÕES CLÍNICAS NA FEBRE CHIKUNGUNYA COM MANIFESTAÇÕES MUSCULOESQUELÉTICAS PERSISTENTES
No full textSeronegative antiphospholipid syndrome
No full textAPS is an autoimmune disease that leads to arterial and-or venous thrombosis, recurrent pregnancy loss and persistently positive aPLs. Patients with clinical manifestations highly suggestive of APS but persistently negative conventional aPLs are classified as having seronegative APS. Ongoing research has revealed the existence of non-criteria antibodies proposed to be relevant to APS and that can be potentially included in the disease's classification criteria. We present a literature review on the most promising antibodies of this heterogeneous aPL family, which includes antibodies to a zwitterionic phospholipid, namely phosphatidylethanolamine, phospholipid-binding plasma proteins, phospholipid-protein complexes and anionic phospholipids other than cardiolipin. Although these molecules can increase the diagnostic yield of APS, their clinical relevance is still debatable and needs to be confirmed by interlaboratory efforts toward standardizing diagnostic tools, in addition to experimental data and larger longitudinal studies. ©The Author 2013. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.Alessandri C, 2011, AUTOIMMUN REV, V10, P609, DOI 10.1016-j.autrev.2011.04.011; Amoroso A, 2003, HUM IMMUNOL, V64, P265, DOI 10.1016-S0198-8859(02)00789-9; Arnold J., 2001, British Journal of Haematology, V113, P911, DOI 10.1046-j.1365-2141.2001.02812.x; Atsumi T, 2000, ARTHRITIS RHEUM, V43, P1982, DOI 10.1002-1529-0131(200009)43:91982::AID-ANR93.0.CO;2-2; Atsumi T, 2010, LUPUS, V19, P436, DOI 10.1177-0961203310361487; Baumgartner P, 2007, J CELL BIOL, V179, P793, DOI 10.1083-jcb.200707165; Berard M, 1996, J RHEUMATOL, V23, P1369; Bertolaccini ML, 2005, THROMB HAEMOSTASIS, V93, P289, DOI 10.1160-TH04-06-0382; Bertolaccini ML, 1998, J RHEUMATOL, V25, P1104; Bertolaccini ML, 2011, LUPUS, V20, P191, DOI 10.1177-0961203310397082; Bertolaccini ML, 2001, J RHEUMATOL, V28, P2637; Bizzaro N, 2007, J THROMB HAEMOST, V5, P1158, DOI 10.1111-j.1538-7836.2007.02532.x; Boilard E, 2003, BLOOD, V102, P2901, DOI 10.1182-blood-2002-12-3702; Branch DW, 1997, OBSTET GYNECOL, V89, P549; CAMPBELL AL, 1995, THROMB HAEMOSTASIS, V73, P529; Caronti B, 1999, CLIN EXP IMMUNOL, V115, P214; Cervera R, 2009, LUPUS, V18, P889, DOI 10.1177-0961203309106832; Conti F, 2003, CLIN EXP IMMUNOL, V132, P509, DOI 10.1046-j.1365-2249.2003.02180.x; Cucurull E, 1999, AM J MED SCI, V318, P55, DOI 10.1097-00000441-199907000-00009; Danowski A, 2006, J RHEUMATOL, V33, P1775; de Laat B, 2005, BLOOD, V105, P1540, DOI 10.1182-blood-2004-09-3387; De Laat B, 2009, J THROMB HAEMOST, V7, P1767, DOI 10.1111-j.1538-7836.2009.03588.x; de Laat B, 2006, ANN RHEUM DIS, V65, P1468, DOI 10.1136-ard.2005.045237; de Laat B, 2007, BLOOD, V109, P1490, DOI 10.1182-blood-2006-07-030148; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182-blood-2005-05-1943; Diri E, 1999, LUPUS, V8, P263, DOI 10.1191-096120399678847812; Donohoe S, 2001, BRIT J HAEMATOL, V113, P544, DOI 10.1046-j.1365-2141.2001.02716.x; Forastiero R, 2010, LUPUS, V19, P109; Forastiero R, 2005, J THROMB HAEMOST, V3, P1231, DOI 10.1111-j.1538-7836.2005.01295.x; Forastiero RR, 1997, THROMB HAEMOSTASIS, V78, P1008; Franck M, 2007, ANGIOLOGY, V58, P295, DOI 10.1177-0003319707302493; Frank M, 2009, AUTOIMMUN REV, V9, P5, DOI 10.1016-j.autrev.2009.02.025; Franklin RD, 2002, HUM REPROD, V17, P2981, DOI 10.1093-humrep-17.11.2981; Franklin RD, 2003, OBSTET GYNECOL, V101, P455, DOI 10.1016-S0029-7844(02)02520-6; Frostegard AG, 2010, SCAND J RHEUMATOL, V39, P77, DOI 10.3109-03009740903124432; Galli M, 1997, THROMB HAEMOSTASIS, V77, P486; Galli M, 1996, LUPUS, V5, P388; Gharavi AE, 1998, LUPUS, V7, pS52; GHARAVI AE, 1987, ANN RHEUM DIS, V46, P1, DOI 10.1136-ard.46.1.1; Giannakopoulos B, 2009, BLOOD, V113, P985, DOI 10.1182-blood-2007-12-129627; Gris JC, 2000, THROMB HAEMOSTASIS, V84, P228; Hirmerova J, 2010, CLIN APPL THROMB-HEM, V16, P318, DOI 10.1177-1076029608331228; Horbach DA, 1996, THROMB HAEMOSTASIS, V76, P916; Hughes GRV, 2003, ANN RHEUM DIS, V62, P1127, DOI 10.1136-ard.2003.006163; Ioannou Y, 2007, ARTHRITIS RHEUM-US, V56, P280, DOI 10.1002-ary.22306; Ioannou Y, 2009, J THROMB HAEMOST, V7, P833, DOI 10.1111-j.1538-7836.2009.03316.x; Iverson GM, 1998, P NATL ACAD SCI USA, V95, P15542, DOI 10.1073-pnas.95.26.15542; Iverson GM, 2002, J IMMUNOL, V169, P7097; Katsuragawa H, 1997, BIOL REPROD, V56, P50, DOI 10.1095-biolreprod56.1.50; Kaul M, 2007, ANN RHEUM DIS, V66, P927, DOI 10.1136-ard.2006.067314; Kutteh WH, 2010, LUPUS, V19, pC156; Lakos G, 1999, CLIN EXP IMMUNOL, V117, P574; Laroche P, 1996, AM J CLIN PATHOL, V106, P549; Lazurova I, 2007, CLIN RHEUMATOL, V26, P1737, DOI 10.1007-s10067-006-0487-8; Lin WS, 2007, ARTHRITIS RHEUM, V56, P1638, DOI 10.1002-art.22522; Mahler M, 2012, AUTOIMMUN REV, V12, P313, DOI 10.1016-j.autrev.2012.05.006; McIntyre JA, 2000, J AUTOIMMUN, V15, P185, DOI 10.1006-jaut.2000.0425; Mehrani T, 2011, J RHEUMATOL, V38, P64, DOI 10.3899-jrheum.100568; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111-j.1538-7836.2006.01753.x; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189-jlb.0405190; Molina JF, 1997, J RHEUMATOL, V24, P291; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038-ncb901; Nojima J, 2001, CLIN CHEM, V47, P1008; Ortona E, 2010, BLOOD, V116, P2960, DOI 10.1182-blood-2010-04-279208; Palosuo T, 1997, THROMB HAEMOSTASIS, V78, P1178; Pengo V, 1996, THROMB HAEMOSTASIS, V75, P721; Petri M, 2010, LUPUS, V19, P419, DOI 10.1177-0961203309360541; PIERANGELI SS, 1995, THROMB HAEMOSTASIS, V74, P1361; Podor TJ, 2002, J BIOL CHEM, V277, P7529, DOI 10.1074-jbc.M109675200; Ramesh S, 2011, J CLIN INVEST, V121, P120, DOI 10.1172-JCI39828; Rand JH, 2006, AM J OBSTET GYNECOL, V194, P182, DOI 10.1016-j.ajog.2005.05.034; Rand JH, 2008, LUPUS, V17, P922, DOI 10.1177-0961203308095029; Rand JH, 2004, BLOOD, V104, P2783, DOI 10.1182-blood-2004-01-0203; Ranzolin Aline, 2004, Arq Bras Cardiol, V83, P141; Rauch J, 1998, THROMB HAEMOSTASIS, V80, P936; Sanmarco M, 2007, THROMB HAEMOSTASIS, V97, P949, DOI 10.1160-TH06-10-0604; Sanmarco M, 2001, THROMB HAEMOSTASIS, V85, P800; Sanmarco M, 2011, CURR RHEUMATOL REP, V13, P81, DOI 10.1007-s11926-010-0147-5; Sanmarco M, 2009, AUTOIMMUN REV, V9, P90, DOI 10.1016-j.autrev.2009.03.007; Selva-O'Callaghan A, 1998, THROMB HAEMOSTASIS, V79, P282; Smirnov MD, 1999, BIOCHEMISTRY-US, V38, P3591, DOI 10.1021-bi982538b; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038-sj.cdd.4401457; Sorice M, 2000, CLIN EXP IMMUNOL, V122, P277, DOI 10.1046-j.1365-2249.2000.01353.x; STAUB HL, 1989, ANN RHEUM DIS, V48, P166, DOI 10.1136-ard.48.2.166; Staub HL, 2006, AUTOIMMUN REV, V6, P104, DOI 10.1016-j.autrev.2006.06.014; Staub HL, 2012, AUTOIMMUN REV, V12, P230, DOI 10.1016-j.autrev.2012.07.008; Staub HL, 2003, ARQ NEURO-PSIQUIAT, V61, P757, DOI 10.1590-S0004-282X2003000500010; Sugi T, 2004, J OBSTET GYNAECOL RE, V30, P326, DOI 10.1111-j.1447-0756.2004.00206.x; Sugi T, 1996, THROMB HAEMOSTASIS, V76, P354; Sugi T, 1999, FERTIL STERIL, V71, P1060, DOI 10.1016-S0015-0282(99)00119-3; Sugi T, 2001, J AUTOIMMUN, V17, P207, DOI 10.1006-jaut.2001.0543; Tebo AE, 2008, CLIN EXP IMMUNOL, V154, P332, DOI 10.1111-j.1365-2249.2008.03774.x; Tebo AE, 2008, AM J CLIN PATHOL, V129, P870, DOI [10.1309-6MPULFBL24FM9B50, 10.1309-6MPULF8L24FM9B50]; Tian Y, 2006, J BIOL CHEM, V281, P28438, DOI 10.1074-jbc.M605861200; Tincani A, 2007, CLIN EXP RHEUMATOL, V25, P268; Tsuda T, 2006, BLOOD COAGUL FIBRIN, V17, P465, DOI 10.1097-01.mbc.0000240919.72930.ee; Tsutsumi Akito, 2006, Mod Rheumatol, V16, P158, DOI 10.1007-s10165-006-0481-7; Vaarala O, 1996, THROMB HAEMOSTASIS, V75, P456; Velayuthaprabhu S, 2011, AM J REPROD IMMUNOL, V66, P373, DOI 10.1111-j.1600-0897.2011.01008.x; WEIDMANN CE, 1988, J RHEUMATOL, V15, P74; Wilson W A, 2001, Lupus, V10, P457, DOI 10.1191-096120301678415999; WONG KL, 1991, J RHEUMATOL, V18, P1187; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128-MCB.24.20.9198-9206.2004; Yetman DL, 1996, FERTIL STERIL, V66, P54058
